The use of shock wave therapy (SWT) and low-intensity pulsed ultrasound (LIPUS) as countermeasures to the inhibited fracture healing experienced during mechanical unloading was investigated by administering treatment to the fracture sites of mature, female, Rambouillet Columbian ewes exposed to partial mechanical unloading or full gravitational loading. The amount of fracture healing experienced by the treatment groups was compared to controls in which identical surgical and testing protocols were administered except for SWT or LIPUS treatment. All groups were euthanized after a 28-day healing period. In vivo mechanical measurements demonstrated no significant alteration in fixation plate strains between treatments within either partial unloading group. Similarly, DXA BMD and 4-point bending stiffness were not significantly altered following either treatment. mCT analyses demonstrated lower callus bone volume for treated animals (SWT and LIPUS, p < 0.01) in the full gravity group but not between reduced loading groups. Callus osteoblast numbers as well as mineralized surface and bone formation rate were significantly elevated to the level of the full gravity groups in the reduced loading groups following both SWT and LIPUS. Although no increase in 4-week mechanical strength was observed, it is possible that an increase in the overall rate of fracture healing (i.e., callus strength) may be experienced at longer time points under partial loading conditions given the increase in osteoblast numbers and bone formation parameters following SWT and LIPUS. ß
The inherent reduction in mechanical loading associated with microgravity has been shown to result in dramatic decreases in the bone mineral density (BMD) and mechanical strength of skeletal tissue. [1] [2] [3] Previous astronaut spaceflight data have demonstrated mean losses in BMD of 1-3% per month in weight bearing skeletal locations. 2 This issue becomes particularly important when considering the implications involved with long-duration spaceflight missions (i.e., to Mars) and the expected resultant declines in skeletal mechanical competency and anticipated increase in fracture risk. 4, 5 In addition to this elevation in fracture risk, previous work has demonstrated that skeletal fracture healing is severely inhibited by the microgravity environment experienced during spaceflight.
3,6-9 Using a rat model, Kerchin et al. showed that bone healing was altered during spaceflight, resulting in suppression of chondrogenesis within the periosteal reaction and angiogenesis within the osteotomy gap. 7 Additionally, Kaplansky et al. 8 reported decreased fracture callus size and strength due to reduced osteoblast activity in rodents during a 14-day spaceflight experiment. Gadomski et al. 6 demonstrated decreased fracture healing rates resulting in diminished callus size and strength due to decreased osteoblast numbers in a ground-based large animal (sheep) model. Based on these findings, it is important to investigate possible countermeasures to the inhibited fracture healing experienced in reduced gravity environments for future long-duration spaceflight missions.
Shock wave therapy (SWT) and low-intensity pulsed ultrasound (LIPUS) have been used to treat soft and hard tissue pathologies by utilizing focused supersonic acoustic waves directed across the affected tissue. While the fundamental mechanism of the two therapies are similar, the energy levels utilized with SWT are much greater than those used with LIPUS. Studies detailing the use of SWT and LIPUS have shown that the administration of supersonic acoustic pulses directly to soft and hard musculoskeletal tissues provides beneficial healing characteristics when used to treat chronic conditions such as tendinopathy, plantar fasciitis, calcaneal spurs, and lateral epicondylitis of the elbow. [10] [11] [12] [13] [14] [15] Most germane to the current work, LIPUS and SWT have been used to treat nonunion and delayed healing of bony fractures in humans by generating low-level mechanical stresses at the fracture site and inducing subsequent cellular and molecular responses involved in the healing cascade.
scenarios such as spaceflight and Earth-based unloading (bedrest). 20, [24] [25] [26] [27] [28] The literature is replete with human clinical studies investigating the use of SWT and LIPUS for the delayed healing of bony fractures. Xu et al. 27 reported a 75.4% success rate in the healing of previous bony nonunions using SWT in various locations including the femur, tibia, radius, and ulna in otherwise healthy middle-aged men and women. A comparative clinical study investigated the use of SWT and intramedullary screw fixation on chronic fracture nonunion of the fifth metatarsal in humans revealed that both therapeutic interventions were effective for the treatment of nonunion; however, a lower complication rate and fewer subsequent surgical procedures were associated with the use of SWT. 29 Human clinical trials have further established the efficacy of LIPUS treatment. A study by Heckman et al. 28 demonstrated a 38% reduction in time to overall clinical and radiographic healing of grade-I open tibial fractures with the use of LIPUS as compared to a control group. These encouraging clinical studies demonstrate the efficacy of SWT and LIPUS to improve fracture healing at the macroscopic level.
At the cellular level, it appears that the beneficial effects of SWT and LIPUS as therapeutic interventions to aberrant fracture healing is a result of increased osteoblast differentiation combined with decreased pro-osteoclastogenic factors. 30, 31 A study to treat fracture healing in rabbits found SWT increased in endothelial nitric oxide synthase (eNOS), bone morphological protein (BMP-2), vessel endothelial growth factor (VEGF), and proliferating cell nuclear antigen (PCNA), leading to resultant increases in fracture healing. 16 Other studies have demonstrated that SWT administration leads to increased fibroblast, chondroblast, and osteoblast differentiation as well as enhanced angiogenesis and increased fluid flow to the fracture site. [31] [32] [33] Given the aforementioned positive findings using LIPUS and SWT as therapies for fracture healing on Earth as well as the critical need for methods to improve fracture healing during long-duration spaceflight, the objective of this study was to interrogate the efficacy of these two therapies as countermeasures to the inhibited fracture healing experienced during partial gravity unloading in a previously developed large animal (sheep) model with the hypothesis that bone formation and strength would be increased following treatment.
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METHODS
A total of twenty-eight skeletally mature, female, Rambouillet Columbian ewes (age >6 years) were included in this study. Animal use approval was granted by the Colorado State University Animal Care and Use Committee (Approval #11-2938A). The experimental group breakdowns and timelines are presented in Figure 1 . Nine animals were randomly allocated to an Earth-based mechanically unloaded (0.25G) group and underwent hindlimb metatarsal unloading as described by Gadomski et al. 1 Briefly, a trans-biarticular external skeletal fixation device (IMEX, Longview, TX) was implanted on the right hindlimb such that the metatarsal bone was isolated from mechanical loading. Previous in vivo experiments demonstrated that this external fixation unloading system was able to reduce metatarsal bone loading by 75%, creating a mean relative gravity environment of 0.25 g. These animals were then exposed to mechanical unloading of the metatarsal bone for a period of 3 weeks (21 days) at which point a 3.0 mm section of bone was removed from the metatarsus via an oscillating bone saw with saline irrigation to simulate a mid-mission diaphyseal fracture. The ostectomy was then stabilized via a laterally attached orthopaedic locking plate (Synthes, Inc., Westchester, PA) instrumented with a rosette strain gage (Vishay Precision Group, Malvern, PA). An additional full gravity group of nine animals (1G Group) was included in which an identical 3.0 mm diaphyseal ostectomy was created, plated, and casted, allowing full loading to be transmitted through the metatarsal bone. SWT was administered to five animals from each of the two groups (0.25G-SWT and 1G-SWT, 2 (five animals were originally allotted to each LIPUS treatment group; however, manufacturing errors in the ultrasonic lens was later discovered and the data from those animals was omitted). The data from ten animals of a previous study were included as control data in which reduced (0.25G-C, n ¼ 5) and full gravity (1G-C, n ¼ 5) control groups underwent the surgical and testing protocols previously described with no administration of treatment (including sham treatments). 6 All animals were housed in pairs in an enclosed pen and were free to ambulate ad arbitrium after the surgery. All groups were euthanized after a 28-day healing period to investigate the acute stages of fracture healing via intravenous injection of Pentobarbital (88 mg/kg) in accordance with the American Veterinary Medical Association guidelines for humane euthanasia.
In Vivo Testing
Dual-energy X-ray absorptiometry (DXA) scans (Discovery A, Hologic, Inc., Bedford, MA) were performed on the treated metatarsi of the 0.25G groups (0.25G-C, 0.25G-SWT, 0.25G-LIPUS) at the time of the external fixation (bone unloading) surgery, the ostectomy (simulated fracture) surgery, and every 2 weeks until sacrifice to obtain a clinical measure of BMD. DXA scans were performed on the 1G groups (1G-C, 1G-SWT, 1G-LIPUS) 3 weeks prior to the ostectomy procedure (time 0), at the time of the ostectomy (simulated fracture) surgery and every 2 weeks until sacrifice. Scans were analyzed in identical 10 mm Â 10 mm regions of interest (ROIs) aligned with the proximal aspect of the condyle arch of the distal metaphysis of the treated metatarsi.
1 Three scans were performed per bone, and the average BMD was calculated per scan time point for each animal. Longitudinal BMD values were normalized to the baseline BMD value for each animal for comparisons between groups.
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In vivo mechanical competency of the healing fracture was evaluated bi-weekly via strain measurements of the orthopaedic plate by testing each animal on a force sensing platform. The instrumented hindlimb of each animal was first suspended to establish a zero-load baseline. Strain measurements from the metatarsal plate for single-limb ground reaction forces up to 200 N were then recorded for the standing animals. The strains measured in the orthopaedic plates were correlated to ground reaction forces between 50 and 200 N, and the resultant slope magnitude (me/N) per testing day was calculated to characterize the change in load burden of the fixation plate and healing fracture for each group over the course of the study. Weekly radiographs were taken to monitor the bone-pin interface of each animal. Fluorochrome labels were administered subcutaneously 21 and 7 days (calcein green at 20 mg/kg) prior to sacrifice.
Biomechanical Evaluation
Following sacrifice (4 weeks post-ostectomy), biomechanical evaluations were performed on the treated metatarsi of each group. Non-destructive four-point bending experiments were performed on the dissected metatarsal bones using a servohydraulic material testing machine (858 Mini Bionix, MTS Systems Corporation, Eden Prairie, MN). The actuator was lowered at a rate of 1.0 mm/sec to 200 N or until the specimen's maximum elastic deflection (i.e., prior to inducing permanent deformation) was achieved. 36 The sample was preconditioned five times and the load-displacement data from the final cycle were utilized to calculate the specimen bending stiffness.
Micro-Computed Tomography
Post-sacrifice micro-computed tomography (mCT) analyses were performed at the fracture location of each group using the following parameters: Voltage: 70 kVp, current: 114 mA, integration time: 500 ms (Scanco mCT 80, Sanco Medical AG, Bruttisellen, Switzerland). A 1.5 mm thick region of interest (ROI) was created within the fracture gap and centered between the proximal and distal bone surfaces to analyze bone volume fraction (BV/TV, %) and BMD (mg HA/cm 3 ). Additionally, the periosteal fracture callus was segmented between the inner-most screw holes of the metatarsal diaphysis (23.0 mm length) to include all external callus while excluding diaphyseal bone to analyze total bone volume (BV, mm 3 ) and BMD (mg HA/cm 3 ).
Histomorphometric Analysis
Each metatarsal bone was processed for decalcified and undecalcified histological analysis. Samples were fixed in 70% ETOH for 2 weeks. For undecalcified preparation, samples were dehydrated in graded solutions of ETOH on a tissue processor (Tissue-Tek VIP, Sakura, Torrance CA). The samples were cleared with acetone and infiltrated with a series of three solutions containing Acrylosin and a catalyst of Percodox 16 (Dorn and Hart Microedge, Villa Park, IL). Samples were placed in solution 1 (100% acrylosin), solution 2 (Acrylosin þ 1/2 catalyst), and solution 3 (Acrylosin þ full catalyst) over the course of approximately 20 days. Upon completion, the specimens were polymerized into a hardened Figure 1 . The experimental group schematic which demonstrates the overall study design. Healing fractures were exposed to either a 0.25G reduced loading environment or a baseline 1G gravitational loading environment. The healing fractures in each gravitational loading group were either received no treatment (0.25G-C and 1G-C groups) or were treated with SWT (0.25G-SWT and 1G-SWT groups) or LIPUS (0.25G-LIPUS and 1G-LIPUS groups). (Bottom) The experimental timeline demonstrates that the reduced gravitational loading groups (0.25G) were first exposed to a 3-week mechanical unloading period prior to undergoing the fracture surgery. All 1G groups experienced an identical 3-week period without unloading prior to the fracture surgery. SWT groups were treated 6 days following the fracture surgery while LIPUS groups began 5 day/week LIPUS treatments that were initiated 2 days following surgery and performed until the time of sacrifice. All groups were sacrificed 4 weeks following the fracture surgery (Healing Period). The LIPUS ultrasound probe was secured to the external fixation frame via a polyethylene fixture to ensure identical placement against the skin overlaying the metatarsal diaphysis between treatment sessions for 0.25G-LIPUS animals. (C) The ultrasound probe was inserted through a pre-drilled hole in the fiberglass cast of 1G-LIPUS animals to attain skin contact and secured via a polyethylene fixture. 
High-resolution digital images were acquired for histomorphometric analysis using a Spot Imaging system (Diagnostic Instruments, Sterling Heights, MI), a Nikon E800 microscope (AG Heinze, Lake Forest, CA), and analyzed with an Image Pro imaging system (Media Cybernetics, Silver Spring, MD). For static histomorphometric analysis, images (at 10Â magnification) were acquired and area fractions of mineralized tissue were calculated in the periosteal callus, diaphyseal cortices, and intramedullary canal. Diaphyseal cortex bone tissue fractional areas (%) were selected within the mediolateral confines of the diaphyseal cortical shell and craniocaudal edges of the fracture gap and calculated by taking the ratio of respective tissue area within the ROI to total ROI area. Intramedullary canal bone tissue fractions (%) were similarly determined by segmenting the images within the confines of the intramedullary canal and within the boundaries of the cranial and caudal fracture gap edges. For all histomorphometric analyses, the ratio of segmented tissue area to the total area of the respective ROI was calculated (BA/TA) to account for variations between specimens. Bone tissue area fractions (%) were calculated for the periosteal callus in the ROI determined by selecting and segmenting callus material contralateral to the orthopaedic plate on the exterior surface of the bone within 11.5 mm of the fracture centrum. For dynamic histomorphometry, three fluorescent images were acquired per specimen (at 40Â magnification) within the periosteal callus and mineralizing surface (MS), mineral apposition rate (MAR), and bone formation rate (BFR) were calculated. 1 Analyses were not performed on the endosteal surface due to the consistent absence of endosteal bone formation. Decalcified cellular histomorphometry was performed on digital images (at 200Â magnification) for three ROIs within the periosteal callus and three ROI's on the endosteal surface per specimen to determine osteoblast (Ob.N) and osteoclast (Oc.N) number.
Statistical Analysis
Statistical analyses were performed using a two-way analysis of variance (ANOVA) for comparisons across groups and a repeated measures one-way analysis of variance (ANOVA) for longitudinal DXA and strain comparisons within groups with Student-Newman-Keuls post hoc tests (a ¼ 0.05). A Kruskal-Wallis ANOVA on ranks was performed in the event that data were not normally distributed (SigmaPlot, Systat Software, Inc., San Jose, CA).
RESULTS
In Vivo Testing
No specimens were omitted from analyses for any analysis. In vivo DXA scans displayed statistically significant losses (p < 0.05) in metatarsal BMD in all 0.25G groups as compared to their respective day-0 baseline BMD values following 21, 35, and 49 days (Fig. 3 ). There were no statistically significant differences between the 0.25G-SWT, 0.25G-LIPUS, or 0.25G-C groups over the course of the study nor were there significant changes in BMD values between 1G groups or within 1G groups as compared to their respective baselines. Increases in callus stiffness, as evidenced by statistically significant decreases in fixation plate strain slope magnitude where experienced by the 0.25G-C, 1G-C, and 1G-SWT groups by the final timepoint as compared to their respective baseline values (Fig. 4) . Significant alterations were not seen in 0.25G-SWT, 0.25G-LIPUS, or 1G-LIPUS groups. groups, respectively (Fig. 5) . 1G-C stiffness was significantly higher than that of the 0.25G-C group (p < 0.05).
Biomechanical Evaluation
Micro-Computed Tomography
Significant alterations in bone volume fraction (BV/TV) and BMD within the fracture gap were not observed following SWT or LIPUS treatment as compared to control specimens for the 0.25 or 1G gravitational groups (Table 1) . Callus BMD of 0.25G-SWT specimens was significantly greater (p < 0.05) than that of 1G-SWT specimens. No other significant alterations in callus BMD were observed. Callus bone volume (BV) was not significantly elevated in 0.25G-SWT or 0.25G-LIPUS groups as compared to 0.25G-C specimens; however, callus BV was significantly reduced in 1G-LIPUS specimens as compared to 1G-C and 1G-SWT specimens (p < 0.05).
Histomorphometric Analysis
Histomorphometric analyses demonstrated significantly elevated callus BA/TA values in 0.25G-LIPUS and 1G-LIPUS specimens as compared to other groups (p < 0.05, Table 1 ). Mean intracortical and intramedullary BA/TA values were elevated in 1 and 0.25G specimens treated with SWT and LIPUS as compared to their respective control groups; however, these alterations were not statistically significant. Cellular numbers as well as bone formation parameters were significantly elevated in the 0.25G-SWT and 0.25G-LIPUS groups as compared to the 0.25G-C group (Fig. 6) . Osteoblast numbers were increased 87 and 120% in 0.25G-SWT and 0.25G-LIPUS specimens as compared to 0.25G-C specimens on the periosteal surface, respectively, and 152 and 244% on the endosteal surface, respectively (p < 0.05). Osteoblast numbers were significantly elevated in 1G-LIPUS specimens as compared to 1G-SWT and 1G-C groups, with increases of 18 and 23% in 1G-SWT and 1G-LIPUS specimens as compared to 1G-C specimens, respectively (p < 0.05). Endosteal osteoblast numbers were not significantly altered in 1G groups following treatment, with observed increases of 2 and 18%, respectively. Periosteal osteoclast numbers were significantly reduced by 82 and 86%, respectively, in 0.25G-SWT and 0.25G-LIPUS specimens as compared to 0.25G-C specimens (p < 0.05). No significant changes in osteoclast numbers were observed in the periosteal callus of 1G specimens, and no significant alterations in osteoclast numbers were observed within 0.25 or 1G groups on the endosteal surface. MS was significantly increased by 53 and 92%, respectively, in 0.25G-SWT and 0.25G-LIPUS specimens as compared to 0.25G-C specimens, while BFR was significantly elevated 88 and 80%, respectively, as compared to 0.25G-C specimens (p < 0.05). Significant changes in MAR were not observed between 0.25G groups, nor were alterations in MS, MAS, and BFR between 1G groups.
DISCUSSION
The increasing duration of space exploration missions and delayed fracture healing experienced during weightlessness makes it imperative to develop feasible countermeasures that may be employed to accelerate bone healing. Additionally, the therapeutic interventions assessed in this study may have other implications such as the delayed fracture healing associated with extended bedrest. This study investigated the effect of SWT and LIPUS on the acute phase (first 28 days) of fracture healing in a partial unloading environment using treatment parameters in accordance with those previously reported for other animal studies for the successful treatment of delayed fracture healing. [17] [18] [19] 37, 38 
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The results of the in vivo DXA scans demonstrated no relationship between SWT or LIPUS and regional metatarsal BMD under 1 or 0.25G loading conditions, indicating that any effects of the two treatments were localized to the healing fracture and did not result in any systemic catabolic or anabolic osteogenic alterations. In vivo measurements of orthopaedic fixation plate strain did not demonstrate significant alterations during the study in the 0.25G-LIPUS and 0.25G-SWT groups whereas a significant increase in callus stiffness was observed in 0.25G-C specimens beginning at day 7 as compared to day 0 baseline values. Significant increases in callus stiffness were observed in 1G-C and 1G-SWT specimens but not in 1G-LIPUS specimens as compared to day 0 baseline readings. It is possible that these differences may be attributed to increased variability in fracture healing due to the experimental therapies, especially during unloading. Despite these differences in healing progression, there were no significant differences in callus stiffness within loading variants at day 28. These findings were further supported by the lack of statistically significant alterations in bending stiffness following SWT or LIPUS treatment under 1 or 0.25G loading. Further, SWT Only relevant statistical differences within loading variants are presented for clarity and are denoted by like letters (p < 0.05). 
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and LIPUS treatment did not alter BMD of the healing callus and fracture gap for both loading conditions. Histomorphometric analyses demonstrated an increase in callus BA/TA in LIPUS specimens, resulting in a more condensed callus than the SWT and control groups for both loading variants. It is possible that the highly concentrated acoustic waves focused on the fracture site directed the location of bone growth. This may also explain why total callus BV was significantly lower in 1G-LIPUS specimens as compared to 1G-SWT and 1G-C specimens despite equivalent mechanical strength. Despite limited changes in mechanical fracture strength 28 days following ostectomy, SWT and LIPUS significantly increased periosteal and endosteal osteoblast numbers while decreasing periosteal osteoclast numbers in 0.25G specimens. These results reflect those observed when SWT and LIPUS were utilized to stimulate murine osteoblast cells, inducing increased osteoblast differentiation and decreased pro-osteoclastogenic factors. 30, 39 Similarly, this study demonstrated significantly elevated MS and BFR within the periosteal callus of 0.25G specimens as a result of both treatments, while not significantly altering MAR values. These data, taken together, indicate that the overall amount of osteoblast activity and the resultant increase in total active surface area, not overall mineralization rate, following LIPUS and SWT were responsible for an overall elevation of bone formation. Additionally, osteoclast numbers on the periosteal and endosteal surfaces were significantly reduced in 0.25G specimens following LIPUS and SWT, but not in 1G specimens. It has been shown that the net loss of BMD during unloading is due to an uncoupling of osteoblast and osteoclast proliferation, resulting in increased osteoclast and decreased osteoblast numbers. The findings of the current study are particularly important as they demonstrated a return in cellular numbers in reduced loading specimens to those experienced in the typical 1G gravitational environment without further uncoupling osteoblast and osteoclast proliferation in 1G loading.
LIPUS and SWT resulted in several similar findings, but numerous results displayed differing characteristics. For example, LIPUS and SWT resulted in increased BA/TA, Ob.N, MS, BFR, and decreased Oc.N under 0.25G loading. Under 1G loading the two treatments shared a similar decrease in BV, but SWT did not reflect the same increases in BA/TA and Ob.N as compared to LIPUS. Perhaps the most important outcome when assessing fracture healing, mechanical strength, was not enhanced at the time of sacrifice (28 days following ostectomy) for either treatment under any loading variant. Complete bridging was not observed in any specimen, indicating that primary bone growth was occurring at the 28-day sacrifice timepoint and agrees with other studies that have used the ovine model. 40, 41 Considering this, it is possible that mechanical integrity would be elevated with respect to control specimens, especially in 0.25G specimens, at longer duration fracture healing given the increased differentiation of osteoblast cells and subsequent increase in BFR. Additionally, an increased rate of callus stiffening in 1G specimens treated with LIPUS and SWT during the final 2 weeks of the study was observed via fixation plate strain measurements (Fig. 4) . Extrapolation of that data would indicate that increased mechanical strength may be possible after 4 weeks of healing. Given that many bone formation parameters were improved with SWT and LIPUS, especially under 0.25G loading, it may be worth considering whether fractures could be effectively treated with a combination of SWT and LIPUS. Further studies would be needed to confirm whether the relatively high energy dose of SWT and the more frequent low energy dosage of LIPUS would be complimentary.
There were several limitations associated with this study. First, the time span of this study allowed the investigation of the acute stages of healing in which signs of aberrant fracture healing would be most critical; however, long-term alterations in fracture healing due to SWT and LIPUS in under reduced loading conditions remain unknown. Further, the localized nature of the unloading technique utilized in this model did not allow the investigation of systemic alterations associated with true microgravity unloading such as changes in fluid balance. Additionally, the fracture healing angiogenic response to microgravity or the therapeutic interventions was not characterized. Finally, control data from this study was derived from a previous study and did not include SWT or LIPUS sham treatments which may have affected the results.
The data reported herein provides strong evidence that SWT and LIPUS elevate osteoblast numbers and bone formation rates as well as decrease osteoclast numbers in a large animal model of partial gravity unloading; however, our hypothesis was only partially confirmed. While bone formation rates were increased following LIPUS and SWT treatment under partialunloading, no increase in 4-week mechanical strength was observed. It is possible that an increase in fracture healing (i.e., callus mechanical competence) would be experienced at longer timepoints under reduced loading conditions given the increase in osteoblast numbers and bone formation parameters following both treatments. Further investigation of the dose-dependent relationship of SWT and LIPUS in a large animal model as well as their effects on longer duration fracture healing will provide valuable information regarding their efficacy as a countermeasure to the inhibited fracture healing encountered during spaceflight. 
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